Bimatoprost/Timolol Versus Travoprost/Timolol

Not Applicable

Completed

• Conditions: Glaucoma
• Interventions: Drug: Ganfort; Drug: Duotrav

• Registration Number: NCT01542710
• Lead Sponsor: Kasr El Aini Hospital

Brief Summary

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Detailed Description

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population.

METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Study Timeline

• Status Verified: 2011-01
• Study Start: 2011-01
• Primary Completion: 2011-12
• Study Completion: 2011-12
• Study First Submitted: 2012-02-06
• Study First Submitted QC: 2012-03-01
• Last Update Submitted: 2012-03-01
• Study First Posted: 2012-03-02
• Last Update Posted: 2012-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Glaucoma

Exclusion Criteria

• No other ocular diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Glaucoma fixed Combination Medications	Ganfort	-
Glaucoma fixed Combination Medications	Duotrav	-

Primary Outcome Measures

Name	Time	Method
Percentage of drop of intraocular pressures from baseline.	1 year

Trial Locations

Locations (1)

Kasr El Aini Hospital; 🇪🇬 Cairo, Egypt